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Background: In monkey, reticulospinal connections to hand and forearm muscles are 
spontaneously strengthened following corticospinal lesion, likely contributing to recovery of 
function. In healthy humans, pairing auditory clicks with electrical stimulation of a muscle 
induces plastic changes in motor pathways (probably including the reticulospinal tract), with 
features reminiscent of spike-timing dependent plasticity. In this study, we tested whether 
pairing clicks with muscle stimulation could improve hand function in chronic stroke survivors.  
Methods: Clicks were delivered via a miniature earpiece; transcutaneous electrical stimuli at 
motor threshold targeted forearm extensor muscles. A wearable electronic device (WD) 
allowed patients to receive stimulation at home while performing normal daily activities. 
Ninety-five patients >6 months post-stroke were randomised to three groups: WD with shock 
paired 12 ms before click; WD with clicks and shocks delivered independently; standard care. 
Those allocated to the device used it for at least 4 hours per day, every day for 4 weeks. Upper 
limb function was assessed at baseline, and weeks 2, 4 and 8, using the Action Research Arm 
Test (ARAT) which has four sub-domains (Grasp, Grip, Pinch and Gross).  
Results: Severity across the three groups was comparable at baseline. Only the Paired 
Stimulation Group showed significant improvement in total ARAT (median baseline: 7.5; 
week 8: 11.5; p=0.019) and the Grasp sub-score (median baseline: 1, week 8: 4; p=0.004).  
Conclusion: A wearable device delivering paired clicks and shocks over four weeks can 
produce a small but significant improvement in upper limb function in stroke survivors.  










Stroke incidence has more than doubled in low- and middle income countries in the last three 
decades1. Among survivors, 30-66% lose the upper limb functions2,3 fundamental to activities 
of daily living. Rehabilitating hand movements is thus essential to restore independence. 
Standard therapist-led approaches can be effective, but access to such resources in low- and 
middle-income countries such as India is extremely limited4. Even in the UK, input from a 
therapist is rare beyond six months post-stroke5; half of UK stroke survivors consider available 
rehabilitation services as suboptimal6.  Effective solutions that complement conventional 
approaches and reduce the contact time required from therapists are clearly needed if the 
outlook for stroke survivors globally is to improve.  
In primates such as humans, motor control is dominated by the corticospinal tract, which is 
responsible for our sophisticated motor repertoire including fine control of independent finger 
movements. Other pathways such as the reticulospinal tract also contribute, even to the control 
of the hand7. The reticulospinal tract (RST) becomes especially important during motor 
recovery after corticospinal damage such as following stroke, when reticulospinal connections 
strengthen8,9, partly subserving recovery10, but also limiting the quality of recovered 
movements8,11. Non-invasive methods to activate and manipulate the RST are limited, but in 
monkey we have shown that loud auditory clicks produce a robust burst of firing in reticular 
cells12. We previously developed a prototype wearable device capable of continually delivering 
clicks paired with transcutaneous electrical stimulation of a muscle while a subject went about 
their normal daily activities13. In healthy human volunteers, this device induced long term 
changes in motor output; the direction of changes (facilitation vs suppression) depended on the 
click-shock interval, as expected if the stimuli induced spike-timing dependent plasticity14 in 
the RST. We therefore hypothesized that this paired stimulation protocol could further 
strengthen RST connections in patients recovering from stroke, yielding improvements in 
upper limb function. 
Aims 
Supported by these recent observations, we developed the wearable device further to be 
suitable for patient use, with the aim of delivering a domiciliary aid to long term rehabilitation. 
Here we present the results of a clinical trial exploring the feasibility, safety and efficacy of 





In this observer-blind, randomised, parallel-group clinical trial, consecutive stroke patients 
attending the neurology out-patient department and/or the stroke clinic of a regional 
neurosciences hospital in Kolkata, India were assessed for their suitability for the study. We 
recruited patients with either haemorrhagic or ischemic hemiparetic stroke with residual upper 
limb weakness at six months or later from stroke onset. Patients were excluded if they had any 
form of aphasia, frank dementia, hearing or visual impairment, had stroke in the 
pontomedullary region, received electrical stimulation as part of their physical therapy, or had 
fixed flexor deformities of the wrist joint.   
A total of 95 patients were recruited. All continued to receive standard treatment; they were 
randomised to receive one of three interventions: Paired Stimulation Group, wearable device 
delivering clicks and shocks paired at a fixed interval; Random Stimulation Group, wearable 
device delivering clicks and shocks at the same rate, but at random with respect to each other; 
Standard Treatment Group, no device. The protocol was approved by the Institutional Ethics 
Committee (reference number INK/EthicsComm/46/2016 dated 2nd April 2016) and written 
informed consent was taken. The protocol was registered with the Clinical Trial Registry of 
India (CTRI/2018/03/012628).  
Assessments  
The outcomes were assessed at baseline (day 0, prior to randomisation to group), week 2, week 
4 and week 8 by a blinded assessor, separate from the study team member who dispensed the 
device to the patients. All assessments were performed by a single assessor (SC) throughout 
the study.  
The primary outcome measure was the Action Research Arm Test (ARAT) for estimation of 
upper limb function15. This is a summated rating scale with four domains – grasp, grip, pinch 
and gross. Scoring was based on the performance of a number of tasks from each domain. Each 
task was rated from 0 to 3, where higher scores denote less disability. There are 19 items in the 
scale, giving a maximum possible score of 57.  
The tone of the forearm flexor group of muscles during passive extension of the wrist was 
assessed using the modified Ashworth scale, which evaluates resistance to passive movement 
on a score from 0 to 416. Increased scores indicate increased tone; although this can be due to 
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spasticity, dystonia, muscle shortening or joint contractions, after stroke spasticity is the major 
contributor.  
The power and pinch grip strength were measured as the average of three measurements with 
electro-dynamometers (G200 and P200, Biometrics Ltd, Newport, UK) of both the affected 
and less affected upper limbs.  
The active range of movement around the wrist joint was measured using an electro-goniometer 
(SG75, Biometrics Ltd, Newport, UK). The participants were requested maximally to extend 
and then flex their wrist from their neutral position, yielding measures of maximum active 
extension and flexion and total range of movement at the wrist.   
Maximum contraction force about the wrist joint was measured using a custom device. Patients 
sat comfortably in a fixed chair, with the forearm and wrist mid-pronated, the hand clamped 
between two vertical plates and the forearm strapped to a cushioned cast. The elbow was held 
at around 90° of flexion and the shoulder in approximately 30° of abduction. A strain gauge 
measured torque in the direction of wrist flexion-extension, about an axis concentric with the 
wrist joint. Subjects were asked to make maximal contractions in flexion and extension three 
times and the maximum values were analysed.  
Signals from power/pinch dynamometers, the goniometer and the wrist strain gauge were 
digitised (power 1401 interface running Spike2 software, Cambridge Electronic Design, 
Cambridge, UK) and stored to hard disc for subsequent off-line analysis. 
The subjective feeling of satisfaction of the patient after using the device was estimated by a 
five-point Likert scale (very satisfied to very dissatisfied).   
Study procedure  
After taking consent and completing the baseline (week 0) assessment, subjects were 
randomised to one of the three groups. Randomisation was performed using a customised 
MATLAB programme. When the sequentially-assigned subject number was inputted, the 
program reported whether the subject was to be issued a device (Paired Stimulation Group or 
Random Stimulation Group) or not (Standard Treatment Group). For the Paired or Random 
Stimulation Groups, the program then generated a coded file which was copied to a microSD 
card and inserted into the device before issue. This instructed the device how to configure the 
stimulation. Randomisation and issuing of the devices was performed by a member of the team 
who was not involved in assessments; this person also fielded any telephone queries from the 
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patients about device function. Patients were instructed not to discuss their device with those 
carrying out assessments. These procedures meant that all team members and the patients were 
blinded to whether patients issued with devices were in Paired or Random Stimulation Groups. 
Those carrying out assessments were completely blind as to group allocation. Randomisation 
was performed block wise: for every three sequentially-recruited patients, one was assigned to 
each group. 
Paired and Random Stimulation Groups were instructed to use the device over four weeks for 
at least 4 hours per day at home from the first day of assessment (see flowchart). Patients were 
told not to use the device when taking a shower or while sleeping, but were otherwise free to 
use it for more than 4 hours per day if they wished. The patients were on stable doses of 
medication and physical therapy from 15 days prior to the baseline visit until the end of the 
study visits. They were instructed immediately to report any medical occurrence during the 
study period. All adverse events were recorded and treated appropriately and further assessed 
for causality.  
Investigational Device  
The device comprised a plastic box (90×60×20mm; see Fig. 1A) containing an electrical 
stimulator (constant current, 220V compliance) and audio amplifier. An inbuilt microprocessor 
read the SD card to determine whether to deliver paired or random stimulation, and also wrote 
files to the SD card logging the number of stimuli given in each session. The device was 
powered by an internal battery which could be recharged via a standard microUSB port. Cables 
led from the device to a miniature earphone which delivered loud clicks (0.1 ms pulse duration; 
intensity 110 dB SPL as in our previous study, which should be consulted for safety 
calculations17) to the ear contralateral to the affected side, and to a pair of adhesive surface 
electrodes (Kendall H34SG) placed over the forearm extensor muscles for transcutaneous 
electrical stimulation (single 0.15 ms pulse, proximal electrode negative17) . The patients and/or 
their immediate family members were trained regarding the placement of electrodes until they 
were confident in achieving reproducible positioning. To ensure patients/carers were 
continuing to place electrodes accurately, this training process was repeated at each visit. A 
knob on the device allowed adjustment of stimulus intensity; patients were told to increase the 
intensity until there was a just-visible extension of the wrist and/or fingers. Stimuli were given 
with an inter-stimulus interval randomly chosen (uniform distribution) from 1250-1750ms. For 
the Paired Stimulation Group, each shock was given 12ms before the click. For the Random 
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Stimulation Group, the click and shock occurred independently at random with the same 
interval distribution as in the Paired Stimulation Group.  
Statistical Analysis 
During study design, limited data were available to perform a power calculation to determine 
optimal sample size. Therefore, 95 consecutive patients were recruited over one year and seven 
months. Measurements from digitised force and wrist angle signals were made using custom 
MATLAB programs. Numerical data were presented as mean and standard deviation (for 
parametric data) or median and inter quartile range (for non-parametric data). Categorical data 
were presented as percentages. Normality was assessed by one sample K-S test and visual 
inspection of the distribution histogram and Q-Q plot, and parametric or non-parametric tests 
selected accordingly. For comparing two groups, we used unpaired t-tests for parametric data 
and Mann Whitney U tests for non-parametric data. The non-parametric data of more than two 
time points for the same patients were compared using Friedman’s ANOVA with post hoc 
Dunn’s tests. The difference between two or more rates/proportions was compared using 
Fisher’s exact test. The correlation between two numerical variables was assessed by 
Spearman’s correlation coefficient (ρ). All participants who completed at least one follow-up 
visit were included for analysis. ‘Intention-to-treat’ analysis was used. However, missing data 
due to dropout of subjects were not replaced by ‘last observed outcome’. The statistical analysis 
was performed using SPSS version 20 (IBM Corporation). 
Results 
The demographic and disease characteristics of the 95 recruited patients are presented in Table 
1. Factors likely to influence motor recovery after stroke were comparable among the three 
randomised groups. There was no significant difference in the total ARAT score across the 
three groups at baseline (median in Paired Stimulation, Random Stimulation and Standard 
Treatment Groups 7.5, 5 and 7 respectively; p=0.194). There was no significant difference 
between the number of stimuli given in the Paired Stimulation or Random Stimulation Groups 
(292±149 versus 243±146 thousand stimuli respectively, mean ± SD, p=0.251).  
The Paired Stimulation Group showed a significant effect of visit number on total ARAT score 
(p=0.019); post-hoc pairwise testing showed an improvement from visit 1 to both visits 3 and 
4 (median ARAT 7.5, 12.5 and 11.5 respectively; p=0.012 and p=0.023; Kendall’s W for visit 
number, used as an estimate of effect size, 0.15). The Random Stimulation and Standard 
Treatment Groups showed no effect of visit number on the total ARAT scores (see Table 2).  
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The above analysis reports changes at a population level; it was also of interest to look at how 
many individual patients showed an improvement. We defined ‘responders’ as patients with at 
least a six-point increase in the total ARAT score (~10% of maximum). Seven patients (29%) 
from the Paired Stimulation Group compared with one (4%) of each of the other two groups 
were responders at visit 3; these proportions were significantly different (p=0.015). The 
response persisted at visit 4 in 5/7 responders from the Paired Stimulation Group.    
The grasp sub-score improved significantly only in the Paired Stimulation Group. The grip, 
pinch and gross sub-scores did not show any significant change in any of the study groups 
(Table 2). Other outcome parameters (modified Ashworth score, isometric grip and wrist 
strength, angular movement around the wrist) did not show significant changes in any group.  
Age, sex, duration since onset of stroke, type of stroke (haemorrhagic/ischaemic infarction), 
affected side (left/right), median baseline ARAT total score and sub-scores were not 
significantly different between responders and non-responders, as classified using visit 3 
scores. The total number of paired stimuli received over the four weeks of device usage was 
significantly correlated with the change in ARAT score at visit 3 (Spearman’s ρ=0.53, p=0.013) 
but not at visit 4 (ρ=0.285, p=0.223).  There was no correlation between the number of stimuli 
received in the Random Stimulation group and ARAT change (Spearman’s ρ= -0.052, p=0.814 
and ρ=0.053, p=0.835 for visits 3 and 4 respectively). 
Trial participants reported that stimulation did not interfere with or interrupt their normal 
activities of daily living, which typically involved light household work or leisure activities. 
Only one patient experienced a device-related adverse event. This individual developed a 
contact dermatitis where the adhesive electrodes had been placed. This improved with topical 
steroid, and did not have an impact on the experimental intervention as electrodes could easily 
be relocated to avoid the skin lesion. All patients successfully used the prototype device, 
although the study identified that the microUSB charge point was weak and prone to breakage 
(four devices over the entire study duration). Two patients disliked the repeated click sound 
and withdrew from the study at visit 2. Forty seven patients out of 64 (73%) who received a 
device intervention were either very satisfied or satisfied with the intervention.  Out of 22 
patients who withdrew from the study by visit 3 (device users), the majority (14) did so because 




In this clinical trial, we observed that the Paired Stimulation Group demonstrated a small but 
statistically significant improvement of upper limb function over the four weeks of device 
usage, which was retained for at least four weeks after device stimulation ceased. Within this 
group, the extent of functional gain was correlated with stimulus number: those patients who 
chose to use the stimulation device for longer each day had better functional improvement. By 
contrast, patients allocated to the control groups (Random Simulation or Standard Treatment) 
did not show a significant improvement, suggesting that the benefit results specifically from 
paired stimulation. 
Various neuromuscular stimulation modalities have been previously used for upper and lower 
limb motor recovery after stroke18-20. Either these devices are used to enhance a weak voluntary 
movement (functional electrical stimulation)21 or stimulate muscles in the absence of any 
simultaneous effort from the patient22. These devices have found to be useful in the majority 
of clinical trials, although the improvement is usually only apparent during the spontaneous 
recovery phase23,24. 
Loud sound is known to be capable of activating not just the cochlea, but also the vestibular 
system; muscle responses to loud clicks are employed routinely for the assessment of the 
functional integrity of vestibular pathways (vestibular evoked myogenic potentials, see 25). 
Previous work has shown that vestibular rehabilitation26-29, rhythmic auditory stimulation30 and 
music therapy31 can all improve gait in stroke survivors. Extra-pyramidal pathways such as the 
vestibulospinal and reticulospinal tract receive strong vestibular and auditory inputs, and are 
intimately associated with the control of posture and locomotion; a contribution from the 
brainstem to recovery of gait might therefore be expected. However, we have shown that the 
reticulospinal tract also contributes to recovery of upper limb function after corticospinal tract 
damage32-34. To date, no studies have considered whether vestibular or auditory stimuli might 
improve rehabilitation of hand movements. Loud clicks can powerfully activate reticulospinal 
cells12, and pairing clicks with peripheral stimuli can induce long-lasting changes in motor 
output consistent with spike-timing dependent plasticity17. These two observations led us to 
the present trial, which represents a novel and unique approach to stimulation-based therapy. 
Our randomised, observer-blind clinical trial demonstrated a significant improvement in total 
ARAT score and the grasp sub-score following paired click and shock stimulation. This 
represents high quality evidence of a benefit at a population level, but on average the changes 
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were small (5 point median change in ARAT). In a chronic hemiparetic population, the 
‘patient-perceived minimal clinically important improvement’ has been estimated as 5.7 
points35 (10% of the maximum possible ARAT score). However, here there was considerable 
inter-individual variation in the extent of improvement.  Better outcomes were associated with 
higher baseline grip strength in the affected hand, and also with using the stimulation device 
for longer each day, thereby delivering more paired stimuli. Thus, when deciding whether to 
use our device for treatment, patients and their caregivers should be informed that only a sub-
set of individuals with specific baseline characteristics demonstrated a significant outcome 
following four weeks of treatment. Future trials must address whether longer durations of 
device intervention beyond the minimum 4 hours per day for 4 weeks tested here could extend 
functional benefits to a wider group of patients. It would also be of interest to combine this 
protocol with other stimulation paradigms which may access different pathways36,37, as this 
could allow synergistic gains in function. 
Recent work in spinal cord injury survivors suggests that high spasticity is associated with 
limited residual corticospinal connections, and enhanced reticulospinal output below the 
lesion38,39; this accords with clinical experience associating spasticity with the reticulospinal 
tract40. Against this background, it might be thought that our intervention, which aimed to 
strengthen reticulospinal outputs, could have risked increasing spasticity. Reassuringly, our 
results yielded no evidence of increases in spasticity as measured by the Modified Ashworth 
Score.  
There is evidence that spontaneous recovery of hand function after stroke relies on two 
separable systems: one provides strength and a limited degree of digit fractionation, whilst the 
other adds further ability to generate independent finger movements41. The system mainly 
responsible for strength recovery may be associated with the reticulospinal tract. This would 
agree with a recent study in our laboratory, where we have revealed a reticulospinal 
contribution to neural adaptations following strength training in healthy monkeys (IS Glover 
& SN Baker, unpublished observations). Despite this, in the present work we found no change 
in grip or wrist strength in the Paired Stimulation Group.  
It is possible that the paired click and shock stimulation exerted its effects on systems other 
than the reticulospinal tract; this could explain why we observed no change in spasticity or 
strength. However, it is likely that the reticulospinal tract has multiple subdivisions, based on 
the reticular nucleus of origin42 and the laterality of both projections to the cord, and control 
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from the cortex43. This richness probably explains why enhanced reticulospinal outputs have 
been associated by different authors with both recovery33,34,44  and poor outcomes11,45. It is 
possible that the paired stimulation used here accessed only a sub-set of reticulospinal outputs, 
yielding an overall positive benefit to hand function. It is also possible that changes were too 
small to generate overt increases in strength, but still sufficient to yield improved control and 
enhanced ARAT scores. 
Examination of the sub-components of the ARAT test showed a significant improvement in 
Grasp, but not in Grip, Pinch or Gross sub-scores. An improvement in hand movements 
requiring less well-fractionated muscle activation (Grasp) rather than fine independent finger 
movements (Grip, Pinch) would be compatible with a contribution from the reticulospinal 
rather than corticospinal tracts46,47. The lack of effect on the Gross subscore may reflect the 
fact that we targeted a forearm extensor muscle for stimulation, rather than more proximal 
muscles. Spontaneous recovery of hand function after stroke is typically imbalanced. Whereas 
wrist and digit flexors often regain strength the extensors remain weak, contributing 
substantially to disability48.  This mirrors the pattern of spontaneous changes in reticulospinal 
connections after corticospinal lesions in monkey: outputs are strengthened to flexors but not 
to extensors33. We recently found that some forms of paired-associative stimulation showed a 
similar bias in their ability to induce plasticity in the corticospinal tract. No matter whether 
flexors or extensor muscles were stimulated, outputs were enhanced to flexors, but not 
extensors37. Although we targeted the forearm extensor muscles in the present trial, we found 
no change in isometric wrist extension strength in any group. Likewise, there was no change 
in active range of movement around the wrist, which is most affected in stroke survivors by 
extensor weakness. This may indicate that, just like the corticospinal tract, the reticulospinal 
tract has only a limited ability for stimulus-induced plasticity in output to extensors. The fact 
that there was, nevertheless, an average improvement in hand function hints at a complex 
reorganisation of control pathways, rather than a simple enhancement of one component. 
One limitation of our study design was that we could not standardise the physical therapy 
program across patients. Many patients were receiving little or no physical therapy. However, 
there were no inter-group differences in the frequency or duration of physical therapy, 
suggesting that this could not have affected our results. We would expect even greater 
functional gains if the stimulation device was used concomitantly with a customised therapy 
regime, ideally at high dosage49.  In this trial we targeted chronic stroke patients, to avoid the 
difficulty of trying to detect benefit against a moving baseline. The lack of significant changes 
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in the control groups confirmed that spontaneous recovery had indeed largely ceased. Stroke 
seems to generate a short-lived window of enhanced plasticity in the acute and sub-acute 
phase50. Using our paired stimulation device during this window might lead to even greater 
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Table 1. Summary and inter-group comparison of demographic and baseline 
characteristics. The difference of numerical variables among three independent groups were 
estimated using one-way ANOVA for parametric data, Kruskal-Wallis H test for non-
parametric data and categorical variables using Fisher’s exact test. P value < 0.05 was 
considered statistically significant (*). MCA, ACA, PCA: Middle, Anterior and Posterior 
Cerebral Artery respectively. 
 Paired  Random  Standard  P value  
Age in years(SD) 51(12.1) 53(9.9) 53(10.6) 0.746 
Male(%) 24(35.8) 25(37.3) 18(26.9) 0.191 
Duration in months 
from onset of 
stroke(SD) 
55(142) 43(94) 30(29) 0.630 
Infarct(%) 19(59.4) 20(62.5) 19(61.3) 1.000 
     
Stable dose of baclofen 
in mg(SD) 
20.4(20.8) 15.6(12.1) 15.6(13.6) 0.474 
Physiotherapy hours 
per week(SD) 
4.2(2.6) 3.5(2.2) 6.1(3.7) 0.203 
Mean ARAT at 
baseline(SD) 
18.3(19.4) 10.8(12.3) 17.3(20.0) 0.194 
Modified Ashworth 
score mean(SD) at 
baseline 
1.5(0.8) 1.9(1.0) 2.1(1.2) 0.179  
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Mean power grip at 
baseline, affected as % 
of unaffected (SD) 
28.9 (22.98) 22.7 (13.16) 30.28 (16.48) 0.216 
Range of movement 
around wrist in degrees 
(SD) 




13(40.6) 16(50.0) 16(51.6) 0.884 
1(3.1) 1(3.1) 1(3.2)  
3(9.4) 1(3.1) 1(3.2)  
 
Table 2: Change in ARAT score and ARAT sub-scores over a period of 8 weeks. The 
difference of numerical variables expressed as median (interquartile range) in multiple time 
points for the same patients were estimated using Friedman’s ANOVA. P value < 0.05 was 
considered statistically significant (*). Pairwise comparison was by post hoc Dunn’s test with 
Friedman’s ANOVA.  






Random 5(3-15) 6.5(4-20.75) 8.5(4-15) 7.5(0.25-18.75) 0.071 
Standard  7(1-32) 10(1.5-24.75) 12(3-31) 9(0-21) 0.794 
 V1-Grasp  V2-Grasp  V3-Grasp  V4-Grasp  P value  
Paired  1(0-12) 3.5(0-14.25) 5(0-13.25) 4(0-14)* 0.004* 
Random 1(0-8) 2(0-9.25) 2.5(0-6.75) 3(0-10) 0.079 
Standard  1(0-11) 10(1.5-24.75) 4(0-11.75) 4(0-8.5) 0.479 
 V1Grip  V2-Grip  V3-Grip  V4-Grip  P value  
Paired  2(0-7) 3(1-7)  2.5(0.5-
6.75) 
3(0.75-14) 0.102 
Random 0.5(0-3.75) 2(0-4.75) 2(0-4) 2(0-4) 0.247 
Standard  2(0-6) 2.5(0-7) 3(0-7.75) 3.5(0-5.5) 0.923 
 V1-pinch V2-pinch V3-pinch V4-pinch  P value  
Paired  0(0-8.25) 0(0-11.5) 0(0-9) 0(0-8.25) 0.055 
Random 0(0-0) 0(0-1) 0(0-1) 0(0-1) 0.050 
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Standard  0(0-8) 0(0-2.75) 0(0-8) 0(0-1.25) 0.491 
 V1-Gross  V2-Gross  V3-Gross  V4-Gross  P value  
Paired  3.5(3-6) 4(3-7.75) 4(3-6.75) 3(3-4.75) 0.121 
Random 3(3-5.5) 3.5(3-6) 4(3-5.75) 3(0-4) 0.215 
Standard  4(0-6) 3.5(0-6) 3.5(3-6) 3.5(1.5-6) 0.324 
 
Figure 1. The experimental device. A, photograph of the device, showing (from left to right): 
connector for stimulating electrodes; knob for adjusting stimulus intensity; audio output to earpiece; 
switch to select between ‘on’ and ‘charge’; LED to indicate when battery is fully charged; microUSB 





































Figure 2. Consort diagram indicating the progress of patients from recruitment to completion of the 
study. Assessments were - Action Research Arm Test; Modified Ashworth Scale; Range of Movement 



















Supplementary table 1: Summary and inter-group comparison of ARAT scores in 
consecutive time points. The difference of numerical variables expressed as mean (standard 
deviation) and median (interquartile range) in multiple groups were estimated using Kruskal-
Wallis ANOVA. P value < 0.05 was considered statistically significant.  
 
Baseline ARAT 
 Paired  Random  Standard  P value  
Mean  18.09  10.75  17.26   
 
0.198 
Median  7.500  5.000  7.000  
Std. Deviation  19.33  12.50  20.27  
25th percentile  3.250  3.000  1.000  
75th percentile  30.50  15.00  32.00  
Week 2 ARAT 
 Paired  Random  Standard  P value  
Mean  20.79  13.29  16.50   
 
0.299 
Median  11.00  6.500  10.00  
Std. Deviation  20.39  13.76  19.19  
25th percentile  5.000  4.000  1.500  
75th percentile  38.00  20.75  24.75  
Week 4 ARAT 
 Paired  Random  Standard  P value  
Mean  20.46  13.46  18.33   
 
0.396 
Median  12.50  8.500  12.00  
Std. Deviation  19.65  15.12  19.34  
25th percentile  4.500  4.000  3.000  
75th percentile  33.50  15.00  31.00  
Week 8 ARAT 
 Paired  Random  Standard  P value  
Mean  19.77  12.00  14.42   
 
0.310 
Median  11.50  7.500  9.000  
Std. Deviation  19.00  14.17  16.38  
25th percentile  5.000  0.2500  0.000  
75th percentile  33.50  18.75  21.00  
 
Supplementary table 2: Summary and inter-group comparison of grasp sub-scores in 
consecutive time points. The difference of numerical variables expressed as mean (standard 
deviation) and median (interquartile range) in multiple groups were estimated using Kruskal-
Wallis ANOVA. P value < 0.05 was considered statistically significant. 
 
Baseline Grasp 
 Paired  Random  Standard  P value  
Mean  5.844  3.531  5.452  
0.709 Median  1.000  1.000  1.000  
Std. Deviation  7.030  4.879  6.707  
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25th percentile  0.000  0.000  0.000  
75th percentile  12.00  8.000  11.00  
Week 2 Grasp 
 Paired  Random  Standard  P value  
Mean  6.679  4.571  5.538  
0.795 
Median  3.500  2.000  2.500  
Std. Deviation  7.409  5.718  6.730  
25th percentile  0.000  0.000  0.000  
75th percentile  14.25  9.250  11.00  
Week 4 Grasp 
 Paired  Random  Standard  P value  
Mean  6.875  4.542  6.208  
0.643 
Median  5.000  2.500  4.000  
Std. Deviation  7.067  5.524  6.541  
25th percentile  0.000  0.000  0.000  
75th percentile  13.25  6.750  11.75  
Week 8 Grasp 
 Paired  Random  Standard  P value  
Mean  7.182  5.053  5.278  
0.652 
Median  4.000  3.000  4.000  
Std. Deviation  7.228  5.602  5.809  
25th percentile  0.000  0.000  0.000  
75th percentile  14.00  10.00  8.500  
 
Supplementary table 3: Summary and inter-group comparison of grip sub-scores in 
consecutive time points. The difference of numerical variables expressed as mean (standard 
deviation) and median (interquartile range) in multiple groups were estimated using Kruskal-
Wallis ANOVA. P value < 0.05 was considered statistically significant. 
 
Baseline Grip 
 Paired  Random  Standard  P value  
Mean  4.063  2.219  3.742  
0.222 
Median  2.000  0.5000  2.000  
Std. Deviation  4.265  2.992  4.531  
25th percentile  0.000  0.000  0.000  
75th percentile  7.000  3.750  6.000  
Week 2 Grip 
 Paired  Random  Standard  P value  
Mean  4.393  2.964  3.731  
0.510 
Median  3.000  2.000  2.500  
Std. Deviation  4.280  3.109  4.387  
25th percentile  1.000  0.000  0.000  
21 
 
75th percentile  7.000  4.750  7.000  
Week 4 Grip 
 Paired  Random  Standard  P value  
Mean  4.250  2.708  4.083  
0.484 
Median  2.500  2.000  3.000  
Std. Deviation  4.173  3.099  4.413  
25th percentile  0.5000  0.000  0.000  
75th percentile  6.750  4.000  7.750  
Week 8 Grip 
 Paired  Random  Standard  P value  
Mean  4.455  2.947  3.722  
0.552 
Median  3.000  2.000  3.500  
Std. Deviation  4.228  3.325  3.997  
25th percentile  0.7500  0.000  0.000  
75th percentile  8.250  4.000  5.500  
 
Supplementary table 4: Summary and inter-group comparison of pinch sub-scores in 
consecutive time points. The difference of numerical variables expressed as mean (standard 
deviation) and median (interquartile range) in multiple groups were estimated using Kruskal-
Wallis ANOVA. P value < 0.05 was considered statistically significant. 
 
Baseline pinch 
 Paired  Random  Standard  P value  
Mean  4.000  1.188  4.032  
0.179 
Median  0.000  0.000  0.000  
Std. Deviation  6.263  3.780  7.007  
25th percentile  0.000  0.000  0.000  
75th percentile  8.250  0.000  8.000  
Week 2 pinch 
 Paired  Random  Standard  P value  
Mean  4.857  1.893  3.154  
0.250 
Median  0.000  0.000  0.000  
Std. Deviation  7.096  4.573  6.123  
25th percentile  0.000  0.000  0.000  
75th percentile  11.50  1.000  2.750  
Week 4 pinch 
 Paired  Random  Standard  P value  
Mean  4.417  2.083  4.000  
0.628 
Median  0.000  0.000  0.000  
Std. Deviation  6.921  5.141  6.897  
25th percentile  0.000  0.000  0.000  
75th percentile  9.000  1.000  8.000  
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Week 8 pinch 
 Paired  Random  Standard  P value  
Mean  3.364  1.368  2.333  
0.985 
Median  0.000  0.000  0.000  
Std. Deviation  6.268  4.112  5.258  
25th percentile  0.000  0.000  0.000  
75th percentile  4.750  1.000  1.250  
 
Supplementary table 5: Summary and inter-group comparison of gross sub-scores in 
consecutive time points. The difference of numerical variables expressed as mean (standard 
deviation) and median (interquartile range) in multiple groups were estimated using Kruskal-
Wallis ANOVA. P value < 0.05 was considered statistically significant. 
Baseline gross 
 Paired  Random  Standard  P value  
Mean  4.250  3.719  3.935  
0.826 
Median  3.500  3.000  4.000  
Std. Deviation  2.615  2.020  3.183  
25th percentile  3.000  3.000  0.000  
75th percentile  6.000  5.500  6.000  
Week 2 gross 
 Paired  Random  Standard  P value  
Mean  4.857  4.214  3.808  
0.510 
Median  4.000  3.500  3.500  
Std. Deviation  2.534  2.250  3.124  
25th percentile  3.000  3.000  0.000  
75th percentile  7.750  6.000  6.000  
Week 4 gross 
 Paired  Random  Standard  P value  
Mean  4.667  4.125  4.042  
0.786 
Median  4.000  4.000  3.500  
Std. Deviation  2.200  2.213  2.805  
25th percentile  3.000  3.000  3.000  
75th percentile  6.750  5.750  6.000  
Week 8 gross 
 Paired  Random  Standard  P value  
Mean  4.773  3.263  3.889  
0.330 
Median  3.000  3.000  3.500  
Std. Deviation  2.349  2.557  2.888  
25th percentile  3.000  0.000  1.500  
75th percentile  7.250  4.000  6.000  
 
 
